Synthesis and biological evaluation of heteroalicyclic cyanoguanidines at histamine receptors.


Journal

Archiv der Pharmazie
ISSN: 1521-4184
Titre abrégé: Arch Pharm (Weinheim)
Pays: Germany
ID NLM: 0330167

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 04 04 2019
revised: 03 05 2019
accepted: 22 05 2019
pubmed: 31 7 2019
medline: 25 1 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

Recent studies on histamine receptor (HR) subtypes identified imidazolyl butyl cyanoguanidines, like UR-PI376, as highly potent agonists at the human histamine H

Identifiants

pubmed: 31359502
doi: 10.1002/ardp.201900107
doi:

Substances chimiques

Guanidines 0
Heterocyclic Compounds 0
Histamine Agonists 0
Ligands 0
Receptors, Histamine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1900107

Informations de copyright

© 2019 Deutsche Pharmazeutische Gesellschaft.

Auteurs

Beatrice Soliman (B)

Institute of Pharmacy, University of Regensburg, Regensburg, Germany.
Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.

Ning Wang (N)

Institute of Pharmacy, University of Regensburg, Regensburg, Germany.

Giuseppe Zagotto (G)

Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.

Steffen Pockes (S)

Institute of Pharmacy, University of Regensburg, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH